Masaki Sato

Title: Masaki Sato and a Patent for Assessing Cardiovascular and Inflammatory Disease Risk.

Introduction

Masaki Sato is an inventor associated with Rockville, Maryland, and the U.S. Department of Health and Human Services. His patent work addresses methods for assessing cardiovascular disease and inflammatory disease risk by examining the function of high-density lipoprotein (HDL).

Latest Patents

Sato is associated with 1 patent, titled “Methods for Assessing Cardiovascular Disease or Inflammatory Disease Risk Using Non-Exchangeable Lipid Probe.” The method incubates a body-fluid sample with donor particles coated with a lipid and a detectably labeled non-exchangeable lipid probe. After separating HDL-associated probe from the donor particles, the method measures the probe transferred to HDL, determines an efflux value, and compares that value with a reference standard to assess disease risk. The patent also describes related methods for measuring functional HDL and for lowering the risk of cardiovascular or inflammatory disease.

Career Highlights

Sato’s listed patent work connects laboratory measurement of lipid transfer with potential assessment of disease risk. The approach focuses on the activity of HDL in a patient’s body-fluid sample rather than relying solely on the amount of HDL present.

Collaborations

Sato’s listed coworker is Edward B. Neufeld. The patent is assigned to the United States of America, as represented by the Secretary of the Department of Health and Human Services.

Conclusion

Masaki Sato’s patent describes a probe-based method for evaluating functional HDL and using its measured activity to assess cardiovascular or inflammatory disease risk.